J.P. Morgan Private Wealth Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-801
| Closed | -$66K | – | 1968 |
|
|
2022
Q3 | $66K | Sell |
801
-22
| -3% | -$1.81K | ﹤0.01% | 1888 |
|
|
2022
Q2 | $56K | Sell |
823
-33
| -4% | -$2.25K | ﹤0.01% | 1894 |
|
|
2022
Q1 | $95K | Sell |
856
-256
| -23% | -$28.4K | ﹤0.01% | 1951 |
|
|
2021
Q4 | $107K | Sell |
1,112
-42
| -4% | -$4.04K | ﹤0.01% | 1940 |
|
|
2021
Q3 | $101K | Sell |
1,154
-343
| -23% | -$30K | ﹤0.01% | 1897 |
|
|
2021
Q2 | $232K | Buy |
1,497
+320
| +27% | +$49.6K | ﹤0.01% | 1784 |
|
|
2021
Q1 | $186K | Sell |
1,177
-24
| -2% | -$3.79K | ﹤0.01% | 1701 |
|
|
2020
Q4 | $279K | Sell |
1,201
-258
| -18% | -$59.9K | ﹤0.01% | 1529 |
|
|
2020
Q3 | $320K | Buy |
1,459
+467
| +47% | +$102K | ﹤0.01% | 1337 |
|
|
2020
Q2 | $282K | Buy |
992
+172
| +21% | +$48.9K | ﹤0.01% | 1329 |
|
|
2020
Q1 | $236K | Buy |
+820
| New | +$236K | ﹤0.01% | 1230 |
|